secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kodiak Sciences Inc. (KOD)
CIK:        0001468748
Form:       8-K
Filed at:   2021-11-09T23:59:59+00:00
Accession:  0000950170-21-003772
Event type: earnings
Sentiment:  negative
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kodiak Q3 net loss $67.5M ($1.30/shr); cash $799M; pipeline on track for 2022 readouts
--------------------------------------------------------------------------------

- Net loss widened to $67.5M ($1.30/shr) from $36.1M ($0.80/shr) in Q3 2020.
- R&D expenses rose to $56.0M (vs $29.3M) on KSI-301 trial and manufacturing costs.
- Cash and equivalents $799.2M; no revenue reported.
- DAZZLE (wet AMD) topline data expected Q1 2022; BEACON (RVO) mid-2022.
- GLEAM/GLIMMER (DME) enrollment target Q1 2022; DAYLIGHT (wet AMD) enrollment 1H 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468748/000095017021003772/0000950170-21-003772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468748/000095017021003772/kod-20211109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-003772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer